A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Breast Cancer|Gastrointestinal Cancer
Interventions: BIOLOGICAL: camrelizumab
Sponsor: Jiangsu HengRui Medicine Co., Ltd.